Cerebrospinal fluid metabolomics: pilot study of using metabolomics to assess diet and metabolic interventions in alzheimer’s disease and mild cognitive impairment

HIGHLIGHTS

• who: Angela J. Hanson and colleagues from the Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington, Seattle, WA, USA have published the research: Cerebrospinal Fluid Metabolomics: Pilot Study of Using Metabolomics to Assess Diet and Metabolic Interventions in Alzheimeru2019s Disease and Mild Cognitive Impairment, in the Journal: Metabolites 2023, 13, x FOR PEER REVIEW of 18/01/2023
• what: This speculation was supported by the observation that cerebral uptake of a labeled ketone (11C-acetoacetate) assessed 10 of 13 with PET in a subset of participants from the trial was increased . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.